The Fullstack Investor
by Lin
v1.3
Explore
1
Watchlist
2
Themes
3
Live Feed
4
Dashboard
5
Earnings
6
TOols
Market Model
Start Here
Connect
Twitter
Login
L
Logout
X
Go Back
Company or ticker...
Arrowhead develops RNA interference drugs that silence disease-causing genes.
Ticker
M. Cap
PS
PE
YTD
10MA
20MA
50MA
200MA
ARWR
12.6B
20.0
n/a
34.84%
Key Facts
Join Now
